JPMorgan Chase & Co’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
+3,576
| New | +$129K | ﹤0.01% | 4687 |
|
|
2025
Q1 | – | Sell |
-173
| Closed | -$5.7K | – | 6594 |
|
|
2024
Q4 | $5.7K | Buy |
+173
| New | +$5.7K | ﹤0.01% | 5445 |
|
|
2024
Q3 | – | Hold |
0
| – | -$6 | – | 6501 |
|
|
2024
Q2 | – | Hold |
0
| – | -$25 | – | 6211 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6128 |
|
|
2023
Q4 | – | Sell |
-6
| Closed | -$11.3K | – | 6725 |
|
|
2023
Q3 | $11.3K | Sell |
6
-4
| -40% | -$7.51K | ﹤0.01% | 5283 |
|
|
2023
Q2 | $51.9K | Sell |
10
-5
| -33% | -$26K | ﹤0.01% | 4851 |
|
|
2023
Q1 | $173K | Buy |
15
+13
| +650% | +$150K | ﹤0.01% | 4396 |
|
|
2022
Q4 | $19K | Buy |
+2
| New | +$19K | ﹤0.01% | 4996 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5449 |
|
|
2022
Q2 | – | Hold |
0
| – | -$66K | – | 5911 |
|
|
2022
Q1 | – | Hold |
0
| – | -$74K | – | 4910 |
|
|
2021
Q4 | – | Hold |
0
| – | -$173K | – | 4934 |
|
|
2021
Q3 | – | Hold |
0
| – | -$139K | – | 4481 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4655 |
|
|
2020
Q4 | – | Hold |
0
| – | -$33K | – | 5094 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4403 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4990 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4987 |
|
|
2018
Q3 | – | Hold |
0
| – | -$131K | – | 4881 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3994 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4789 |
|
|
2017
Q4 | – | Hold |
0
| – | -$3K | – | 4728 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4177 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4510 |
|
|
2016
Q3 | – | Hold |
0
| – | -$27K | – | 4254 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3659 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4280 |
|